...
search icon
scnx-img

Scienture Holdings, Inc., Common Stock

SCNX

NAQ

$0.8764

-$0.01

(-1.12%)

1D

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$11.69M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
62.37K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.69 L
$22.18 H
$0.8764

About Scienture Holdings, Inc., Common Stock

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company operates through Integra and Scienture segments. The Integra segment engages in the wholesale and sale of licensed pharmaceutical brand, generic, and non-drug products. The Scienture segment researches and develops branded pharmaceutical products. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen. It also develops SCN-106, which is a thrombolytic agent that binds to fibrin in clots and converts entrapped plasminogen to plasmin; and SCN-107, a long-acting injection suspension formulation of a non-opioid analgesic for postsurgical local and regional analgesia. Scienture Holdings, Inc. is based in Tampa, Florida. more

Returns

Data is not properly formatted.

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue17.12M9.89M10.25M1.36M136.64K[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":57.76,"profit":true},{"date":"2022-12-31","value":59.86,"profit":true},{"date":"2023-12-31","value":7.97,"profit":true},{"date":"2024-12-31","value":0.8,"profit":true}]
Cost of Revenue11.42M5.14M4.73M1.31M130.64K[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":45.06,"profit":true},{"date":"2022-12-31","value":41.44,"profit":true},{"date":"2023-12-31","value":11.52,"profit":true},{"date":"2024-12-31","value":1.14,"profit":true}]
Gross Profit5.71M4.75M5.52M49.03K6.00K[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":83.16,"profit":true},{"date":"2022-12-31","value":96.71,"profit":true},{"date":"2023-12-31","value":0.86,"profit":true},{"date":"2024-12-31","value":0.11,"profit":true}]
Gross Margin33.33%47.99%53.85%3.60%4.39%[{"date":"2020-12-31","value":61.9,"profit":true},{"date":"2021-12-31","value":89.13,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":6.68,"profit":true},{"date":"2024-12-31","value":8.16,"profit":true}]
Operating Expenses8.21M10.04M8.44M4.45M14.71M[{"date":"2020-12-31","value":55.85,"profit":true},{"date":"2021-12-31","value":68.25,"profit":true},{"date":"2022-12-31","value":57.36,"profit":true},{"date":"2023-12-31","value":30.23,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(2.51M)(5.29M)(2.92M)(4.40M)(14.70M)[{"date":"2020-12-31","value":-250666200,"profit":false},{"date":"2021-12-31","value":-529229300,"profit":false},{"date":"2022-12-31","value":-291596900,"profit":false},{"date":"2023-12-31","value":-439645100,"profit":false},{"date":"2024-12-31","value":-1470101500,"profit":false}]
Total Non-Operating Income/Expense(58.78K)(47.18K)197.31K(5.23M)(5.28M)[{"date":"2020-12-31","value":-29.79,"profit":false},{"date":"2021-12-31","value":-23.91,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-2648.34,"profit":false},{"date":"2024-12-31","value":-2675.06,"profit":false}]
Pre-Tax Income(2.54M)(5.32M)(2.40M)(8.48M)(18.78M)[{"date":"2020-12-31","value":-253605100,"profit":false},{"date":"2021-12-31","value":-531588300,"profit":false},{"date":"2022-12-31","value":-240344200,"profit":false},{"date":"2023-12-31","value":-848286400,"profit":false},{"date":"2024-12-31","value":-1877887600,"profit":false}]
Income Taxes----(534.40K)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-53439600,"profit":false}]
Income After Taxes----(18.24M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-1824448000,"profit":false}]
Income From Continuous Operations(2.54M)(5.32M)(2.40M)(8.48M)(18.24M)[{"date":"2020-12-31","value":-253605100,"profit":false},{"date":"2021-12-31","value":-531588300,"profit":false},{"date":"2022-12-31","value":-240344200,"profit":false},{"date":"2023-12-31","value":-848286400,"profit":false},{"date":"2024-12-31","value":-1824448000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(2.54M)(5.32M)(3.47M)(17.84M)9.07M[{"date":"2020-12-31","value":-27.97,"profit":false},{"date":"2021-12-31","value":-58.64,"profit":false},{"date":"2022-12-31","value":-38.3,"profit":false},{"date":"2023-12-31","value":-196.82,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
EPS (Diluted)(4.74)(9.80)(6.15)(21.43)17.03[{"date":"2020-12-31","value":-27.85,"profit":false},{"date":"2021-12-31","value":-57.56,"profit":false},{"date":"2022-12-31","value":-36.13,"profit":false},{"date":"2023-12-31","value":-125.82,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

SCNX
Current Ratio 1.05

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

SCNX
ROA (LTM) 0.00%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

SCNX
Debt Ratio Lower is generally better. Negative is bad. 0.24
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.76

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

SCNX
Trailing PE NM
Forward PE 21.83
P/S (TTM) 0.00
P/B 0.32
Price/FCF NM
EV/R 4.11
EV/Ebitda NM

FAQs

What is Scienture Holdings, Inc. share price today?

Scienture Holdings, Inc. (SCNX) share price today is $0.8764

Can Indians buy Scienture Holdings, Inc. shares?

Yes, Indians can buy shares of Scienture Holdings, Inc. (SCNX) on Vested. To buy Scienture Holdings, Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SCNX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Scienture Holdings, Inc. be purchased?

Yes, you can purchase fractional shares of Scienture Holdings, Inc. (SCNX) via the Vested app. You can start investing in Scienture Holdings, Inc. (SCNX) with a minimum investment of $1.

How to invest in Scienture Holdings, Inc. shares from India?

You can invest in shares of Scienture Holdings, Inc. (SCNX) via Vested in three simple steps:

  • Click on Sign Up or Invest in SCNX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Scienture Holdings, Inc. shares
What is Scienture Holdings, Inc. 52-week high and low stock price?

The 52-week high price of Scienture Holdings, Inc. (SCNX) is $22.18. The 52-week low price of Scienture Holdings, Inc. (SCNX) is $0.69.

What is Scienture Holdings, Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Scienture Holdings, Inc. (SCNX) is 0.32

What is the Market Cap of Scienture Holdings, Inc.?

The market capitalization of Scienture Holdings, Inc. (SCNX) is $11.69M

What is Scienture Holdings, Inc.’s stock symbol?

The stock symbol (or ticker) of Scienture Holdings, Inc. is SCNX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top